Westat, Inc. was awarded a $30.5 million cost-plus-fixed-fee modification to an existing contract with the Centers for Disease Control and Prevention (CDC) to expand a virtual network study assessing COVID-19 vaccine effectiveness. Under the modification, Westat will extend its work through September 2023 to evaluate additional populations including children, compare benefits of extra vaccine doses, and monitor declines in effectiveness over time. The original solicitation sought to add over 3.5...
This is a $889,592.00 delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Childrens Hospital Medical Center, a non-profit hospital and research center in Cincinnati, Ohio. The contract is part of the CDC's Clinical Immunization Safety Assessment (CISA) program, which evaluates vaccine safety data and provides clinical expertise to support the Department of Health and Human Services' (HHS) vaccine safety monitoring efforts. Under this task order, Childrens Hospital...
The Johns Hopkins University (JHU) was awarded a definitive cost-no-fee contract valued at $3.51 million by the Centers for Disease Control and Prevention (CDC) to conduct the JHU COVID-19 Pediatric Study. The study will be performed over 14 months in Baltimore, Maryland and aims to advance the CDC's understanding of coronavirus disease 2019 (COVID-19) transmission and severity among children. Major subcontractors include Abt Associates Inc. to develop and administer a study database and provide...
<p>The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $250,000.00 Firm Fixed Price Definitive Contract to the National Association of Community Health Centers, Inc. for a VACCINE STUDY. The contract was awarded on September 29, 2017 with a completion date of September 25, 2018. The place of performance is in Atlanta, Georgia. This contract does not have a set-aside designation.</p>
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $100,000.00 firm fixed price purchase order contract to The Workers Compensation Research Institute, a non-profit organization, for a COVID-19 special study. The contract, which does not have a set-aside designation, requires the delivery of data services, report analysis, and workers' compensation studies related to injury cause, nature, body part, and COVID-19 impacts. These services...
This is a $245,000.00 firm-fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, PA to Emory University, a private research institution in Atlanta, GA. The contract is for a study titled "TAF-EVG INSERT STUDY" with a completion date of September 28, 2025. The contract does not have a set-aside designation. Emory University, through its Office of Sponsored Programs Division, is a major recipient of federal contracts and...
Vanderbilt University Medical Center was awarded a definitive cost-plus-fixed-fee contract valued at $14,222,774.34 by the Centers for Disease Control and Prevention under funding opportunity announcement topic 9.3. The prime contractor will lead a network of subcontractors to conduct a prospective cohort study to assess the effectiveness of COVID-19 and influenza vaccines in preventing virus transmission within households. Major subcontractors include the Universities of Arizona, Emory,...
The Centers for Disease Control and Prevention awarded a $2.8 million firm fixed price contract to Laboratory Corporation of America, operating as Labcorp, to provide residual blood specimen collection and SARS-CoV-2 serology testing services under the Multistate Assessment of SARS-CoV-2 Seroprevalence study. Labcorp will collect approximately 33,800 residual sera samples per month from all 50 states, Washington D.C. and Puerto Rico, distributed by age, and test for SARS-CoV-2 nucleocapsid...
The Centers for Disease Control and Prevention (CDC) awarded a $249,572 firm fixed price purchase order to The Trustees of Columbia University in the City of New York, operating as the Health Sciences Division, to conduct a MPOX viral persistency study. As the prime contractor, Columbia University will perform the study under the contract's one-year period of performance in New York, New York. The CDC aims to enhance understanding of MPOX through research administered under its broader health...
The Centers for Disease Control and Prevention (CDC) awarded a $249,000 firm fixed-price purchase order to The Trustees of Columbia University in the City of New York to conduct a prospective long-term follow-up study on COVID-19 patients who developed neurological manifestations, with a focus on Hispanic/Latinx populations. The study aims to recruit 150 participants and collect and analyze data on neurocognitive effects, biomarkers, and neuroradiological features over 24 months. This...